-
1
-
-
36148985293
-
Visual acuity in 3422 consecutive eyes with choroidal nevus
-
DOI 10.1001/archopht.125.11.1501
-
Shields CL, Furuta M, Mashayekhi A, et al. Visual acuity in 3422 consecutive eyes with choroidal naevus. Arch Ophthalmol 2007;125:1501-7. (Pubitemid 350106682)
-
(2007)
Archives of Ophthalmology
, vol.125
, Issue.11
, pp. 1501-1507
-
-
Shields, C.L.1
Furuta, M.2
Mashayekhi, A.3
Berman, E.L.4
Zahler, J.D.5
Hoberman, D.M.6
Dinh, D.H.7
Shields, J.A.8
-
2
-
-
0017339192
-
Problems in the differential diagnosis of choroidal nevi and malignant melanomas. The XXXIII Edward Jackson Memorial Lecture
-
Gass JD. Problems in the differential diagnosis of choroidal naevi and malignant melanomas. The XXXIII Edward Jackson Memorial Lecture. Am J Ophthalmol 1977;83:299-323. (Pubitemid 8063257)
-
(1977)
American Journal of Ophthalmology
, vol.83
, Issue.3
, pp. 299-323
-
-
Gass, J.D.M.1
-
3
-
-
20344369539
-
Variable outcome of photodynamic therapy for choroidal neovascularization associated with choroidal nevus
-
DOI 10.1097/00006982-200506000-00007
-
Parodi MB, Boscia F, Piermarocchi S, et al. Variable outcome of photodynamic therapy for choroidal neovascularization associated with choroidal naevus. Retina 2005;25:438-42. (Pubitemid 40791880)
-
(2005)
Retina
, vol.25
, Issue.4
, pp. 438-442
-
-
Parodi, M.B.1
Boscia, F.2
Piermarocchi, S.3
Ferrari, T.M.4
Furino, C.5
Sborgia, C.6
-
4
-
-
84855195195
-
Intravitreal bevacizumab for choroidal neovascularization associated with choroidal naevus
-
Chiang A, Bianciotto C, Maguire JI, et al. Intravitreal bevacizumab for choroidal neovascularization associated with choroidal naevus. Retina 2012;32:60-7.
-
(2012)
Retina
, vol.32
, pp. 60-67
-
-
Chiang, A.1
Bianciotto, C.2
Maguire, J.I.3
-
6
-
-
0027246303
-
Choroidal neovascularization associated with choroidal naevi
-
Callahan DG, Lewis ML, Byrne SF, et al. Choroidal neovascularization associated with choroidal naevi. ArchOphthalmol 1993;111:789-94.
-
(1993)
ArchOphthalmol
, vol.111
, pp. 789-794
-
-
Callahan, D.G.1
Lewis, M.L.2
Byrne, S.F.3
-
7
-
-
0041326319
-
Photodynamic therapy for choroidal neovascularization secondary to choroidal nevus
-
DOI 10.1016/S0002-9394(03)00321-0
-
Stanescu D, Wattenberg S, Cohen SY. Photodynamic therapy for choroidal neovascularization secondary to choroidal naevus. Am J Ophthalmol 2003;136:575-6. (Pubitemid 37101271)
-
(2003)
American Journal of Ophthalmology
, vol.136
, Issue.3
, pp. 575-576
-
-
Stanescu, D.1
Wattenberg, S.2
Cohen, S.Y.3
-
8
-
-
23044445757
-
Treatment of subfoveal choroidal neovascularization secondary to choroidal nevus using photodynamic therapy
-
Levy J, Shneck M, Klemperer I, et al. Treatment of subfoveal choroidal neovascularization secondary to choroidal naevus using photodynamic therapy. Ophthalmic Surg Lasers Imaging 2005;36:343-5. (Pubitemid 41073115)
-
(2005)
Ophthalmic Surgery Lasers and Imaging
, vol.36
, Issue.4
, pp. 343-345
-
-
Levy, J.1
Shneck, M.2
Klemperer, I.3
Lifshitz, T.4
-
9
-
-
11144308808
-
Transpupillary thermotherapy for subfoveal choroidal neovascularization associated with choroidal nevus
-
DOI 10.1016/j.ajo.2004.06.059, PII S0002939404008098
-
Parodi MB. Transpupillary thermotherapy for subfoveal choroidal neovascularization associated with choroidal naevus. Am J Ophthalmol 2004;138:1074-5. (Pubitemid 40040040)
-
(2004)
American Journal of Ophthalmology
, vol.138
, Issue.6
, pp. 1074-1075
-
-
Parodi, M.B.1
-
10
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
DOI 10.1056/NEJMoa054481
-
Rosenfeld PJ, Brown DM, Heier JS, et al. MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31. (Pubitemid 44511557)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.14
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
Boyer, D.S.4
Kaiser, P.K.5
Chung, C.Y.6
Kim, R.Y.7
-
11
-
-
57949094834
-
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study
-
ANCHOR Study Group
-
Brown DM, Michels M, Kaiser PK, et al. ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009;116:57-65.e5.
-
(2009)
Ophthalmology
, vol.116
-
-
Brown, D.M.1
Michels, M.2
Kaiser, P.K.3
-
12
-
-
84863327423
-
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: One-year findings from the IVAN randomized trial
-
IVAN Study Investigators
-
Chakravarthy U, Harding SP, Rogers CA, et al., IVAN Study Investigators. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology 2012;119:1399-411.
-
(2012)
Ophthalmology
, vol.119
, pp. 1399-1411
-
-
Chakravarthy, U.1
Harding, S.P.2
Rogers, C.A.3
-
13
-
-
84863320414
-
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-year results
-
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group
-
Martin DF, Maguire MG, Fine SL, et al., Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 2012;119:1388-98.
-
(2012)
Ophthalmology
, vol.119
, pp. 1388-1398
-
-
Martin, D.F.1
Maguire, M.G.2
Fine, S.L.3
-
14
-
-
84870723704
-
Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration
-
VIEW 1 and VIEW 2 Study Groups
-
Heier JS, Brown DM, Chong V, et al. VIEW 1 and VIEW 2 Study Groups. Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration. Ophthalmology 2012;119:2537-48.
-
(2012)
Ophthalmology
, vol.119
, pp. 2537-2548
-
-
Heier, J.S.1
Brown, D.M.2
Chong, V.3
-
15
-
-
73349109509
-
Outer retinal tubulation: A novel optical coherence tomography finding
-
Zweifel SA, Engelbert M, Laud K, et al. Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol 2009;127:1596-602.
-
(2009)
Arch Ophthalmol
, vol.127
, pp. 1596-1602
-
-
Zweifel, S.A.1
Engelbert, M.2
Laud, K.3
|